NASDAQ:ANAB - AnaptysBio, Inc.
$55.66
 $1.12
+2.05%
4:00PM EDT
2019-07-15
AnaptysBio, Inc., incorporated on November 16, 2005, is a clinical stage biotechnology company. The Company is engaged in developing antibody product candidates focused on inflammation. The Company is engaged in developing product candidates to address emerging biological targets using its antibody discovery technology platform, which is based upon the understanding of the natural process of antibody generation, known as somatic hypermutation (SHM), and replicates this natural process of antibody generation in vitro.The Companys antibody programs, ANB020 and ANB019, neutralize therapeutic targets that are genetically associated with severe inflammatory disorders in humans. ANB020 inhibits the activity of the interleukin-33 (IL-33), cytokine for the treatment of moderate-to-severe adult atopic dermatitis, severe adult peanut allergy and severe adult eosinophilic asthma. The Company has completed a Phase I trial of ANB020 in healthy volunteers in Australia. The Companys product candidate, ANB019, inhibits the interleukin-36 (IL-36R), receptor for the treatment of rare inflammatory diseases, including generalized pustular psoriasis (GPP), and palmo-plantar pustular psoriasis (PPP). The Company focuses on commencing a Phase I clinical trial of ANB019. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ANAB     avg for
industry  
  avg for
sector  
42 stocks weight:  46. 20   114. 77   204. 78  
42 stocks rank:  2. 38 K 1. 44 K 810. 33  
# analyst opinions:  10. 00   13. 59   13. 86  
mean recommendation:  2. 00   2. 12   2. 04  

quick ratio:  16. 80   5. 48   1. 89  
current ratio:  17. 05   5. 85   2. 40  

target price low:  74. 00   82. 72   115. 11  
target price avg:  115. 00   104. 42   138. 02  
target price high:  153. 00   130. 64   159. 47  
1-yr high:  101. 95   110. 27   142. 72  
last close:  54. 54   85. 12   126. 54  
50-day avg:  67. 03   86. 06   122. 35  
200-day avg:  71. 58   88. 76   121. 75  
1-yr low:  53. 76   69. 26   100. 63  
volume:  171. 61 K 3. 51 M 5. 53 M
50-day avg volume:  298. 17 K 3. 21 M 4. 22 M
200-day avg volume:  304. 94 K 3. 04 M 4. 75 M

1-day return:  0. 79 % -0. 30 % -1. 01 %
this week return:  1. 45 % -2. 16 % -1. 35 %
12-wk return:  -26. 30 % 3. 34 % 8. 69 %
52-wk return:  -25. 98 % -1. 76 % 12. 22 %

enterprise value (EV):  1. 08 B 46. 50 B 123. 99 B
market cap:  1. 48 B 40. 77 B 109. 11 B
EBITDA:  -75. 36 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -14. 33   5. 45   12. 05  
enterprise/revenue (EV/R):  215. 96   50. 46   9. 50  
total revenue:  5. 00 M 10. 21 B 40. 60 B
total debt:  8. 60 M 11. 27 B 17. 58 B
debt/equity:  1. 84   57. 36   120. 25  
net income (common):  -68. 65 M 2. 13 B 4. 27 B

shares outstanding:  0. 00   551. 08 M 1. 24 B
shares:  21. 66 M 559. 41 M 1. 22 B
shares short:  3. 97 M 11. 15 M 11. 94 M
shares short prior month:  3. 66 M 9. 31 M 11. 96 M
short ratio:  10. 48   5. 72   3. 43  
short % of float:  23. 42 % 6. 40 % 2. 65 %
total cash/share:  15. 38   11. 00   9. 23  
total cash:  415. 66 M 6. 03 B 6. 01 B
free cash flow:  -30. 22 M 3. 02 B 4. 96 B
operating cash flow:  -52. 13 M 3. 92 B 5. 99 B

book value:  17. 34   13. 02   27. 49  
price/book:  3. 15   4. 21   8. 80  
gross profits:  -51. 20 M 7. 67 B 36. 29 B
operating margins:  -1514. 74 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  11. 51 % --- ---
1-yr mean volatility:  2. 69 % 1. 50 % 1. 08 %

1-yr EPS:  -2. 70   2. 12   4. 26  
forward EPS:  -4. 68   3. 47   7. 14  
P/E:  -20. 22   2. 15   33. 17  
forward P/E:  -11. 56   -4. 03   17. 60  
PE/G:  5. 34   0. 54   0. 34  
growth:  -3. 79 % 263. 03 % 78. 34 %
earnings high:  -0. 85   0. 91   1. 70  
earnings avg:  -0. 99   0. 71   1. 58  
earnings low:  -1. 22   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -11. 70 % -2. 31 % 5. 31 %
return on equity:  -18. 00 % -82. 48 % 135. 30 %
revenue/share:  0. 20   12. 77   61. 38  

beta (1yr vs S&P500):  1. 61   1. 26   0. 91  
sharpe (1yr):  -0. 21   0. 07   0. 77  

held % insiders:  1. 32 % 6. 08 % 3. 31 %
held % institutions:  113. 23 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : ANAB
.    145.514 =       145.514 :: --> INITIAL WEIGHT <--
.    - 2.697 =       142.817 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.407 =       343.828 :: P/E factor
.    x 0.876 =       301.079 :: PE/G factor
.    x 1.575 =       474.091 :: beta factor
.    x 0.715 =       338.757 :: sharpe factor
.    x 2.912 =       986.391 :: current ratio factor
.    x 1.031 =      1017.129 :: quick ratio factor
.    x 1.047 =      1064.551 :: short ratio factor
.    x 3.142 =      3344.384 :: EV/R factor
.    x 1.034 =      3458.383 :: price-to-book factor
.    x 0.848 =      2932.404 :: debt-to-revenue factor
.    x 1.016 =      2978.992 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =      6297.544 :: sector+industry 1-year gains factor
.    x 1.033 =      6507.869 :: industry 12-weeks return factor
.    x 1.305 =       8494.55 :: industry 2-weeks return factor
.     x 0.94 =       7986.63 :: company one-year gains+dividend factor
.    x 0.983 =      7854.066 :: company 13 weeks' performance factor
.     / 1.99 =       3946.52 :: overall "drift" factor
.     x 0.79 =      3116.096 :: largest single-day jump factor
.     x 0.99 =      3085.583 :: volatility factor
.    x 0.991 =      3058.149 :: 42-day volatility factor
.    x 2.215 =      6774.647 :: notable returns + performance factor
.    x 2.948 =     19969.147 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.612 =      12218.38 :: forward EPS factor
.    x 0.859 =     10495.083 :: forward P/E factor
.    x 1.182 =     12409.899 :: industry recommendation factor
.    x 2.233 =      27710.25 :: company recommendation factor
.    x 1.008 =     27922.187 :: factor historical industry gain for week 28
.    x 1.741 =     48615.797 :: target low factor
.    x 1.351 =     65677.904 :: target mean factor
.    x 1.056 =     69384.207 :: target high factor
.   x 11.443 =    793973.717 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         29.85 :: reduced for readability
.   + 16.351 =        46.201 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     46.201 :: FINAL WEIGHT for NASDAQ:ANAB


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org